Table 5. Age and sex-specific 10-, 20-, 30- and 40-year and lifetime risk estimates for coronary heart disease based on Non-high-density lipoprotein cholesterol level (adjusted for the competing risk of death).
| Sex | Index age (yrs) | Short and intermediate term risk (Yrs) | Non-HDL-C Categories |
|
|---|---|---|---|---|
| Low Non-HDL-C | High Non-HLDL-C | |||
| Men | 45 | 10 | 0.2 (0.0–0.5) | 5.1 (0.7–9.5) |
| 20 | 2.5 (1.4–3.7) | 9.2 (3.9–14.4) | ||
| 30 | 5.2 (3.7–6.8) | 17.3 (11.0–23.6) | ||
| 40 | 9.5 (7.5–11.6) | 25.2 (17.6–32.9) | ||
| LTR | 12.7 (9.9–15.4) | 41.45 (25.0–57.7) | ||
| 55 | 10 | 2.4 (1.3–3.5) | 4.3 (0.9–7.7) | |
| 20 | 5.2 (3.7–6.7) | 13.1 (7.7–18.5) | ||
| 30 | 9.5 (7.5–11.6) | 21.7 (14.4–28.9) | ||
| LTR | 12.7 (9.9–15.6) | 39.9 (21.7–56.4) | ||
| 65 | 10 | 3.0 (1.8–4.2) | 9.5 (4.8–14.3) | |
| 20 | 7.7 (5.7–9.7) | 18.8 (11.5–26.1) | ||
| LTR | 11.2 (8.3–14.0) | 37.7 (19.1–56.3) | ||
| 75 | 10 | 5.9 (3.9–7.9) | 11.6 (4.3–19.0) | |
| LTR | 10.2 (7.0–13.5) | 35.3 (12.5–58.2) | ||
| Women | 45 | 10 | 0.5 (0.0–0.9) | 0.0 (0.0–0.0) |
| 20 | 0.6 (0.1–1.1) | 0.8 (0.0–1.9) | ||
| 30 | 1.3 (0.5–2.0) | 4.7 (2.3–7.2) | ||
| 40 | 4.9 (3.1–6.6) | 9.1 (5.0–13.1) | ||
| LTR | 7.2 (4.5–9.9) | 10.5 (5.6–15.3) | ||
| 55 | 10 | 0.1 (0.0–0.4) | 0.8 (0.0–2.0) | |
| 20 | 0.8 (0.2–1.4) | 4.9 (2.4–7.4) | ||
| 30 | 4.5 (2.7–6.2) | 9.4 (5.2–13.6) | ||
| LTR | 6.9 (4.2–9.6) | 10.9 (5.9–15.9) | ||
| 65 | 10 | 0.7 (0.1–1.3) | 4.3 (1.9–6.6) | |
| 20 | 4.5 (2.7–6.3) | 8.9 (4.7–13.2) | ||
| LTR | 7.0 (4.2–9.8) | 10.5 (5.4–15.6) | ||
| 75 | 10 | 4.1 (2.3–5.9) | 5.2 (1.2–9.2) | |
| LTR | 6.8 (3.8–9.7) | 6.9 (1.8–12.0) | ||
HDL-C: high-density lipoprotein cholesterol, LTR: lifetime risk
Serum non-HDL-C < 190 mg/dL was defined as “Low non-HDL-C”.
Serum non-HDL-C ≥ 190 mg/dL was defined as “High non-HDL-C”.